ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

ClinicalTrials.gov ID: NCT05987423

Public ClinicalTrials.gov record NCT05987423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Moderate-to-Severe Thyroid Eye Disease

Study identification

NCT ID
NCT05987423
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
131 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Satralizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2023
Primary completion
Jul 7, 2025
Completion
Jun 4, 2026
Last update posted
May 4, 2026

2023 – 2026

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
Thrive Health Research LLC Beverly Hills California 90210
UCSD Shiley Eye Center La Jolla California 92093-0946
Grene Vision Group, LLC Wichita Kansas 67206
Johns Hopkins University Baltimore Maryland 21205
University of Michigan, Kellogg Eye Center Ann Arbor Michigan 48105
Great Lakes Eye Care Saint Joseph Michigan 49085
'Northwell Health Physician Partners Ophthalmology Great Neck New York 11021
EyeHealth Northwest Portland Oregon 97225
Austin Retina Associates Austin Texas 78705-1169
Eyelid Center of Utah Salt Lake City Utah 84102
WVU Eye Institute Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05987423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05987423 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →